American Well Corporation (AMWL) has a MoatMap StockRank of 84/100 based on Quality (45/100), Value (49/100), and Momentum (75/100) factor scores. The current signal is STRONG BUY. American Well is an unprofitable telehealth provider with a broken business model and declining customer retention, completely violating our quality and margin of safety requirements.
American Well Corporation (Amwell) provides an enterprise-grade telehealth platform that enables digital care delivery for health systems, health plans, and innovators. The company's competitive moat is its highly integrated, white-label Amwell Converge platform, which embeds directly into existing clinical workflows. It operates as a leading B2B digital health technology provider in the United States.
| Price | $8.50 |
| Market Cap | $158M |
| P/E (Forward) | -5.23 |
| Price/Book | 0.64 |
| Return on Equity | -31.8% |
| Return on Invested Capital | -42.0% |
| Debt/Equity | 1.65 |
| Gross Margin | 53.8% |
| Operating Margin | -23.6% |
| Revenue Growth | -17.9% |
| Free Cash Flow | $-12M |
American Well Corporation operates in the Health Information Services industry, part of the Healthcare sector (United States).